{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:04:31Z","timestamp":1789387471644,"version":"build-2803163510"},"reference-count":30,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/na","name":"Henan Province for Young Teachers","doi-asserted-by":"publisher","award":["2023GGJS009"],"award-info":[{"award-number":["2023GGJS009"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373630"],"award-info":[{"award-number":["82373630"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Overexpression and abnormal activation of membrane proteins promote malignant tumor cell proliferation, while traditional interventions are often limited by drug resistance caused by target mutations. Here, we designed a stimulus-responsive DNA tetrahedron lysosome-targeted chimera (tFNA-LYTAC) strategy for degrading embrane proteins. Two tetrahedra are modified with trivalent HER2 aptamers (tFNA1-Apt) and trivalent IGF2R aptamers (tFNA2-Apt), enabling targeted binding to HER2 and IGF2R, and are then self-assembled into tFNA-LYTAC under VEGF stimulation to promote HER2 degradation. The trivalent aptamer modification strategy significantly enhances the overall binding capacity of tFNA1-Apt to cells. Importantly, tFNA-LYTAC formed only in the presence of VEGF, integrating tetrahedral multivalent aptamer targeting with stimulus responsiveness to improve the degradation specificity. VEGF-responsive tFNA-LYTAC promoted HER2 degradation and suppressed the phosphorylation of key downstream signaling proteins. The study innovatively proposes a \u201ctarget recognition-stimulus response-endocytic degradation\u201d mode that selectively regulates membrane proteins through programmable multivalent aptamer nanostructures.<\/jats:p>","DOI":"10.1021\/acs.biomac.6c00257","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:01:52Z","timestamp":1786042912000},"page":"5887-5897","source":"Crossref","is-referenced-by-count":0,"title":["Stimuli-Responsive\nDNA Tetrahedral Lysosome-Targeting\nChimeras for Enhanced HER2 Protein Degradation"],"prefix":"10.1021","volume":"27","author":[{"given":"Lulu","family":"Song","sequence":"first","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Guo","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]},{"name":"The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital , , ,","place":["Zhengzhou, China, 450008"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Yang","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiong","family":"Hu","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-3962","authenticated-orcid":true,"given":"Songcheng","family":"Yu","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3437-1451","authenticated-orcid":true,"given":"Leiliang","family":"He","sequence":"additional","affiliation":[{"name":"Zhengzhou University , , No.100 Science Avenue , ,","place":["Zhengzhou City, China, 450001"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026091407063620100_cit1","doi-asserted-by":"publisher","first-page":"10681","DOI":"10.1021\/acs.nanolett.4c03217","article-title":"Clustering of the Membrane Protein\nby Molecular Self-Assembly Downregulates the Signaling Pathway for\nCancer Cell Inhibition","volume":"24","author":"Li","year":"2024","journal-title":"Nano Lett."},{"key":"2026091407063620100_cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108641","article-title":"Amiloride synergizes\nwith EGFR PROTACs and inhibitors to overcome therapeutic resistance\nin NSCLC","volume":"163","author":"Qu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"2026091407063620100_cit3","doi-asserted-by":"publisher","first-page":"33648","DOI":"10.1021\/acsami.5c06626","article-title":"Dual-Targeting Strategy\nto Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of\nTriple-Negative Breast Cancer","volume":"17","author":"Barbieri","year":"2025","journal-title":"ACS Appl. Mater.\nInterfaces."},{"key":"2026091407063620100_cit4","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202503958","article-title":"Nanoparticle-Mediated\nTargeted Protein Degradation: An Emerging Therapeutics Technology","volume":"64","author":"Baker","year":"2025","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026091407063620100_cit5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1021\/acsnano.4c11903","article-title":"Strategy and\nDesign of In Situ Activated Protein Hydrolysis Targeted Chimeras","volume":"19","author":"Lv","year":"2025","journal-title":"ACS Nano"},{"key":"2026091407063620100_cit6","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202417942","article-title":"A Bifunctional Lysosome-Targeting Chimera Nanoplatform for Tumor-Selective\nProtein Degradation and Enhanced Cancer Immunotherapy","volume":"37","author":"Xing","year":"2025","journal-title":"Adv. Mater."},{"key":"2026091407063620100_cit7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56648-6","article-title":"A covalent peptide-based lysosome-targeting protein degradation platform\nfor cancer immunotherapy","volume":"16","author":"Xiao","year":"2025","journal-title":"Nat. Commun."},{"key":"2026091407063620100_cit8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41587-022-01456-2","article-title":"Modular\ncytokine receptor-targeting chimeras for targeted degradation of cell\nsurface and extracellular proteins","volume":"41","author":"Pance","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"2026091407063620100_cit9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein\ndegradation: mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026091407063620100_cit10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for\ndegradation of extracellular\nproteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"2026091407063620100_cit11","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6249","article-title":"Elucidating\nthe cellular determinants of targeted membrane protein degradation\nby lysosome-targeting chimeras","volume":"382","author":"Ahn","year":"2023","journal-title":"Science"},{"key":"2026091407063620100_cit12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","article-title":"LYTACs that engage the asialoglycoprotein receptor\nfor targeted protein degradation","volume":"17","author":"Ahn","year":"2021","journal-title":"Nat. Chem.\nBiol."},{"key":"2026091407063620100_cit13","doi-asserted-by":"publisher","first-page":"11267","DOI":"10.1002\/anie.202102170","article-title":"Bispecific Aptamer Chimeras Enable Targeted Protein Degradation on\nCell Membranes","volume":"60","author":"Miao","year":"2021","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026091407063620100_cit14","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202218106","article-title":"Aptamer-LYTACs for\nTargeted Degradation of Extracellular and Membrane Proteins","volume":"62","author":"Wu","year":"2023","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026091407063620100_cit15","doi-asserted-by":"publisher","first-page":"25490","DOI":"10.1021\/jacs.4c04794","article-title":"Development of Integrin-Facilitated\nBispecific Aptamer Chimeras for Membrane Protein Degradation","volume":"146","author":"Sun","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026091407063620100_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308924","article-title":"Multivalent Aptamer-Based Lysosome-Targeting Chimeras (LYTACs) Platform\nfor Mono- or Dual-Targeted Proteins Degradation on Cell Surface","volume":"11","author":"Duan","year":"2024","journal-title":"Adv. Sci."},{"key":"2026091407063620100_cit17","doi-asserted-by":"publisher","first-page":"24506","DOI":"10.1021\/jacs.3c03899","article-title":"Covalent LYTAC Enabled by DNA Aptamers\nfor Immune Checkpoint Degradation Therapy","volume":"145","author":"Li","year":"2023","journal-title":"J.\nAm. Chem. Soc."},{"key":"2026091407063620100_cit18","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1021\/jacs.2c10428","article-title":"Cancer Cell-Selective Membrane Receptor\nClustering Driven by VEGF Secretion for In Vivo Therapy","volume":"145","author":"Bi","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"2026091407063620100_cit19","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1078-0432.CCR-23-1526","article-title":"The VEGF-Hypoxia Signature Is Upregulated in Basal-like\nBreast Tumors from Women of African Ancestry and Associated with Poor\nOutcomes in Breast Cancer","volume":"30","author":"Han","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"2026091407063620100_cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2025.137963","article-title":"Tumor microenvironment-responsive\nnanoregulator CoMnMOF superparticles for enhanced microwave dynamic\ntherapy via multi-pronged amplification of reactive oxygen species","volume":"697","author":"Wang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"2026091407063620100_cit21","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-022-00199-9","article-title":"Advances in\nregenerative medicine applications of tetrahedral\nframework nucleic acid-based nanomaterials: an expert consensus recommendation","volume":"14","author":"Lin","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"2026091407063620100_cit22","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41596-022-00791-7","article-title":"A dynamic DNA tetrahedron framework\nfor active targeting","volume":"18","author":"Tian","year":"2023","journal-title":"Nat. Protoc."},{"key":"2026091407063620100_cit23","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1021\/acs.analchem.1c03682","article-title":"Topological\nDNA Tetrahedron Encapsulated Gold Nanoparticle Enables Precise Ligand\nEngineering for Targeted Cell Imaging","volume":"93","author":"Tang","year":"2021","journal-title":"Anal.\nChem."},{"key":"2026091407063620100_cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.120677","article-title":"Simultaneous\nfluorescent detection of multiplexed miRNA of liver cancer based on\nDNA tetrahedron nanotags","volume":"210","author":"Zhao","year":"2020","journal-title":"Talanta"},{"key":"2026091407063620100_cit25","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1021\/jacs.0c11245","article-title":"DNA-Based\nDynamic Mimicry of Membrane Proteins for Programming Adaptive Cellular\nInteractions","volume":"143","author":"Li","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"2026091407063620100_cit26","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100395","article-title":"Consensus for HER2\nalterations testing\nin non-small-cell lung cancer","volume":"7","author":"Ren","year":"2022","journal-title":"ESMO Open"},{"key":"2026091407063620100_cit27","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1039\/D4SC08004A","article-title":"A supramolecular FRET signal amplification\nnanoprobe for high contrast and synchronous in situ imaging of cell\nsurface receptor homodimers\/heterodimers","volume":"16","author":"Wang","year":"2025","journal-title":"Chem.\nSci."},{"key":"2026091407063620100_cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101575","article-title":"Emerging treatments in HER2-positive\nadvanced breast cancer: Keep raising the bar","volume":"5","author":"Agostinetto","year":"2024","journal-title":"Cell Rep. Med."},{"key":"2026091407063620100_cit29","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01899-w","article-title":"Therapeutic advances\nof targeting receptor tyrosine\nkinases in cancer","volume":"9","author":"Tomuleasa","year":"2024","journal-title":"Signal Transduction Targeted\nTher."},{"key":"2026091407063620100_cit30","doi-asserted-by":"publisher","DOI":"10.3390\/bios12121145","article-title":"Current Status\nand Future Perspectives of Lactate Dehydrogenase\nDetection and Medical Implications: A Review","volume":"12","author":"Zhou","year":"2022","journal-title":"Biosensors"}],"container-title":["Biomacromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.biomac.6c00257","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article-pdf\/27\/9\/5887\/66450621\/acs.biomac.6c00257.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article-pdf\/27\/9\/5887\/66450621\/acs.biomac.6c00257.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:15:08Z","timestamp":1789384508000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bomaf6\/article\/27\/9\/5887\/5249773\/Stimuli-Responsive-DNA-Tetrahedral-Lysosome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,6]]},"published-print":{"date-parts":[[2026,9,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.biomac.6c00257","relation":{},"ISSN":["1525-7797","1526-4602"],"issn-type":[{"value":"1525-7797","type":"print"},{"value":"1526-4602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}